August 9, 2017
Otsuka Holdings President Tatsuo Higuchi Otsuka Holdings saw its pharmaceutical revenue inch up 0.8% year on year to 373,761 million yen in the first half of 2017 as shriveling sales of Abilify (aripiprazole), the company’s flagship antipsychotic hit by a...read more